177 related articles for article (PubMed ID: 25736604)
1. Structural studies of the C-terminal 19-peptide of serum amyloid A and its Pro → Ala variants interacting with human cystatin C.
Maszota M; Karska N; Spodzieja M; Ciarkowski J; Kołodziejczyk AS; Rodziewicz-Motowidło S; Czaplewska P
J Mol Recognit; 2015 Jul; 28(7):413-26. PubMed ID: 25736604
[TBL] [Abstract][Full Text] [Related]
2. Interaction of serum amyloid A with human cystatin C--identification of binding sites.
Spodzieja M; Szymańska A; Kołodziejczyk A; Prądzińska M; Maszota M; Stefanowicz P; Szewczuk Z; Grubb A; Czaplewska P
J Mol Recognit; 2012 Oct; 25(10):513-24. PubMed ID: 22996594
[TBL] [Abstract][Full Text] [Related]
3. Interaction of serum amyloid A with human cystatin C--assessment of amino acid residues crucial for hCC-SAA formation (part II).
Spodzieja M; Rafalik M; Szymańska A; Kołodziejczyk AS; Czaplewska P
J Mol Recognit; 2013 Sep; 26(9):415-25. PubMed ID: 23836469
[TBL] [Abstract][Full Text] [Related]
4. Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides.
Egashira M; Takase H; Yamamoto I; Tanaka M; Saito H
Arch Biochem Biophys; 2011 Jul; 511(1-2):101-6. PubMed ID: 21569756
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of C-terminal, β-amyloid peptide binding fragment of neuroprotective protease inhibitor, cystatin C.
Spodzieja M; Kalejta K; Kołodziejczyk AS; Maszota-Zieleniak M; Rodziewicz-Motowidło S; Żmudzińska W; Czaplewska P
J Mol Recognit; 2017 Feb; 30(2):. PubMed ID: 27714883
[TBL] [Abstract][Full Text] [Related]
6. Defining lipid-binding regions of human serum amyloid A using its fragment peptides.
Ohta S; Tanaka M; Sakakura K; Kawakami T; Aimoto S; Saito H
Chem Phys Lipids; 2009 Nov; 162(1-2):62-8. PubMed ID: 19665458
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.
Colón W; Aguilera JJ; Srinivasan S
Adv Exp Med Biol; 2015; 855():117-34. PubMed ID: 26149928
[TBL] [Abstract][Full Text] [Related]
9. Effect of lipid environment on amyloid fibril formation of human serum amyloid A.
Tanaka M; Nishimura A; Takeshita H; Takase H; Yamada T; Mukai T
Chem Phys Lipids; 2017 Jan; 202():6-12. PubMed ID: 27865770
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.
Elimova E; Kisilevsky R; Ancsin JB
FASEB J; 2009 Oct; 23(10):3436-48. PubMed ID: 19549924
[TBL] [Abstract][Full Text] [Related]
11. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
Lu J; Yu Y; Zhu I; Cheng Y; Sun PD
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5189-94. PubMed ID: 24706838
[TBL] [Abstract][Full Text] [Related]
12. Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with beta-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation.
Juszczyk P; Paraschiv G; Szymanska A; Kolodziejczyk AS; Rodziewicz-Motowidlo S; Grzonka Z; Przybylski M
J Med Chem; 2009 Apr; 52(8):2420-8. PubMed ID: 19317448
[TBL] [Abstract][Full Text] [Related]
13. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
14. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
Ancsin JB; Kisilevsky R
J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
[TBL] [Abstract][Full Text] [Related]
15. Hypothetical structure of human serum amyloid A protein.
Stevens FJ
Amyloid; 2004 Jun; 11(2):71-80. PubMed ID: 15478462
[TBL] [Abstract][Full Text] [Related]
16. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
18. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
19. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
[TBL] [Abstract][Full Text] [Related]
20. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
